{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:15:10Z","timestamp":1780604110991,"version":"3.54.1"},"reference-count":136,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2015_A171"],"award-info":[{"award-number":["2015_A171"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2013_A182"],"award-info":[{"award-number":["2013_A182"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["694913"],"award-info":[{"award-number":["694913"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["314061271 - TRR 205"],"award-info":[{"award-number":["314061271 - TRR 205"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RE 752\/20-1"],"award-info":[{"award-number":["RE 752\/20-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.beem.2019.101365","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T05:47:36Z","timestamp":1575524856000},"page":"101365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Prevalence, diagnosis and outcomes of treatment for primary aldosteronism"],"prefix":"10.1016","volume":"34","author":[{"given":"Yuhong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy Ann","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2019.101365_bib1","first-page":"3","article-title":"Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome","volume":"45","author":"Conn","year":"1955","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.beem.2019.101365_bib2","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101365_bib3","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.beem.2019.101365_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beem.2019.101365_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2019.101365_bib6","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101365_bib7","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.beem.2019.101365_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2019.101365_bib9","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1681\/ASN.2004100878","article-title":"Relative glomerular hyperfiltration in primary aldosteronism","volume":"16","author":"Ribstein","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.beem.2019.101365_bib10","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","article-title":"Long-term renal outcomes in patients with primary aldosteronism","volume":"295","author":"Sechi","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.beem.2019.101365_bib11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1210\/jc.2008-1851","article-title":"Risk factors associated with a low glomerular filtration rate in primary aldosteronism","volume":"94","author":"Reincke","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101365_bib12","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1210\/jc.2008-2245","article-title":"Intrarenal hemodynamics in primary aldosteronism before and after treatment","volume":"94","author":"Sechi","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101365_bib13","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1097\/HJH.0b013e3283495cbb","article-title":"Primary aldosteronism: changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment","volume":"29","author":"Wu","year":"2011","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.beem.2019.101365_bib14","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and characteristics of the metabolic syndrome in primary aldosteronism","volume":"91","author":"Fallo","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101365_bib15","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1210\/jc.2012-3934","article-title":"Aldosterone excess impairs first phase insulin secretion in primary aldosteronism","volume":"98","author":"Fischer","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101365_bib16","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1530\/EJE-15-0450","article-title":"Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry","volume":"173","author":"Hanslik","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2019.101365_bib17","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2337\/dc18-1293","article-title":"High prevalence of diabetes in patients with primary aldosteronism (PA) associated with subclinical hypercortisolism and prediabetes more prevalent in bilateral than unilateral PA: a large, multicenter cohort study in Japan","volume":"42","author":"Akehi","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2019.101365_bib18","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1210\/jc.2009-1763","article-title":"Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism","volume":"95","author":"Sukor","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101365_bib19","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1210\/jc.2011-0138","article-title":"Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and\/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically","volume":"96","author":"Ahmed","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101365_bib20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2017-01442","article-title":"Quality of life in primary aldosteronism: a comparative effectiveness study of adrenalectomy and medical treatment","volume":"103","author":"Velema","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101365_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jc.2017-02141","article-title":"Anxiety, depression, and impaired quality of life in primary aldosteronism: why we shouldn't ignore it!","volume":"103","author":"Reincke","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101365_bib22","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/HYPERTENSIONAHA.117.10111","article-title":"Old and new concepts in the molecular pathogenesis of primary aldosteronism","volume":"70","author":"Prada","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2019.101365_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1055\/a-0713-0629","article-title":"Inherited forms of primary hyperaldosteronism: new genes, new phenotypes and proposition of a new classification","volume":"127","author":"Perez-Rivas","year":"2019","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.beem.2019.101365_bib24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/joim.12831","article-title":"Diagnosis and treatment of primary aldosteronism: practical clinical perspectives","volume":"285","author":"Young","year":"2019","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.beem.2019.101365_bib25","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJM196711162772002","article-title":"Diagnosis and localization of aldosterone-producing adenomas by adrenal-vein cateterization","volume":"277","author":"Melby","year":"1967","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2019.101365_bib26","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101365_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/archinte.1956.00250200011001","article-title":"Aldosterone in clinical medicine; past, present, and future","volume":"97","author":"Conn","year":"1956","journal-title":"AMA Arch Intern Med"},{"key":"10.1016\/j.beem.2019.101365_bib28","series-title":"Aldosterone and aldosteronism","author":"Ross","year":"1975"},{"key":"10.1016\/j.beem.2019.101365_bib29","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","article-title":"A\u00a0screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients","volume":"141","author":"Hiramatsu","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.beem.2019.101365_bib30","first-page":"S310","article-title":"How common is primary aldosteronism? Is it the most frequent cause of curable hypertension?","volume":"11","author":"Gordon","year":"1993","journal-title":"J\u00a0Hypertens Suppl"},{"key":"10.1016\/j.beem.2019.101365_bib31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","article-title":"High incidence of primary aldosteronism in 199 patients referred with hypertension","volume":"21","author":"Gordon","year":"1994","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.beem.2019.101365_bib32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s11906-001-0045-3","article-title":"Primary aldosteronism: rare bird or common cause of secondary hypertension?","volume":"3","author":"Stowasser","year":"2001","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.beem.2019.101365_bib33","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis","volume":"101","author":"Kayser","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101365_bib34","first-page":"2854","article-title":"Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore","volume":"85","author":"Loh","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101365_bib35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2019.101365_bib36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1291\/hypres.27.193","article-title":"Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan","volume":"27","author":"Omura","year":"2004","journal-title":"Hypertens Res"},{"key":"10.1016\/j.beem.2019.101365_bib37","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1373\/clinchem.2004.041780","article-title":"Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity","volume":"51","author":"Schwartz","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/j.beem.2019.101365_bib38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/02813430600830931","article-title":"High frequency of primary hyperaldosteronism among hypertensive patients from a primary care area in Sweden","volume":"24","author":"Westerdahl","year":"2006","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.beem.2019.101365_bib39","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.jhh.1001948","article-title":"Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia","volume":"20","author":"Williams","year":"2006","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.beem.2019.101365_bib40","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1291\/hypres.30.111","article-title":"Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone\/renin ratio above 25 as a screening test","volume":"30","author":"Fogari","year":"2007","journal-title":"Hypertens Res"},{"key":"10.1016\/j.beem.2019.101365_bib41","first-page":"57","article-title":"Primary aldosteronism among newly diagnosed and untreated hypertensive patients in a Swedish primary care area","volume":"29","author":"Westerdahl","year":"2011","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.beem.2019.101365_bib42","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/10641963.2017.1339072","article-title":"Prevalence of primary aldosteronism without hypertension in the general population: results in Shika study","volume":"40","author":"Karashima","year":"2018","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.beem.2019.101365_bib43","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.3399\/bjgp18X694589","article-title":"Prevalence of primary aldosteronism in primary care: a cross-sectional study","volume":"68","author":"Kayser","year":"2018","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.beem.2019.101365_bib44","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2019.101365_bib45","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A\u00a0prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.beem.2019.101365_bib46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ancard.2016.04.016","article-title":"Causes of secondary hypertension in the young population: a monocentric study","volume":"65","author":"Noilhan","year":"2016","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"10.1016\/j.beem.2019.101365_bib47","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.4158\/E161332.OR","article-title":"Prevalence of primary aldosteronism in an urban hypertensive population","volume":"22","author":"Galati","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/j.beem.2019.101365_bib48","first-page":"8295010","article-title":"Detection of secondary causes and coexisting diseases in hypertensive patients: OSA and PA are the common causes associated with hypertension","volume":"2017","author":"Wang","year":"2017","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.beem.2019.101365_bib49","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/HJH.0000000000001511","article-title":"Screening of primary aldosteronism by clinical features and daily laboratory tests: combination of urine pH, sex, and serum K","volume":"36","author":"Yamashita","year":"2018","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.beem.2019.101365_bib50","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/HJH.0000000000001885","article-title":"Prevalence of potential modifiable factors of hypertension in patients with difficult-to-control hypertension","volume":"37","author":"Van Der Sande","year":"2019","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.beem.2019.101365_bib51","article-title":"Higher screening aldosterone to renin ratio in primary aldosteronism patients with diabetes mellitus","volume":"7","author":"Chang","year":"2018","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.beem.2019.101365_bib52","doi-asserted-by":"crossref","first-page":"293","DOI":"10.21037\/atm.2018.06.25","article-title":"Improved identification of secondary hypertension: use of a systematic protocol","volume":"6","author":"Kotliar","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.beem.2019.101365_bib53","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.endinu.2018.11.008","article-title":"Primary aldosteronism: aldosterone\/renin ratio cut-off points","volume":"66","author":"Eugenio Russmann","year":"2019","journal-title":"Endocrinol Diabetes Nutr"},{"key":"10.1016\/j.beem.2019.101365_bib54","doi-asserted-by":"crossref","first-page":"58","DOI":"10.29271\/jcpsp.2019.01.58","article-title":"Frequency of primary hyperaldosteronism in young hypertensives in a tertiary care setting of Rawalpindi","volume":"29","author":"Gilani","year":"2019","journal-title":"J\u00a0Coll Physicians Surg Pak"},{"key":"10.1016\/j.beem.2019.101365_bib55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1470320310366581","article-title":"Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism","volume":"11","author":"Di Murro","year":"2010","journal-title":"J\u00a0Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.beem.2019.101365_bib56","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/HJH.0b013e3283492219","article-title":"Positive relationship of sleep apnea to hyperaldosteronism in an ethnically diverse population","volume":"29","author":"Sim","year":"2011","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.beem.2019.101365_bib57","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1055\/s-0043-122887","article-title":"Primary aldosteronism and obstructive sleep apnea: is this a bidirectional relationship?","volume":"49","author":"Prejbisz","year":"2017","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.beem.2019.101365_bib58","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJM196511182732106","article-title":"Hypertension, the potassium ion and impaired carbohydrate tolerance","volume":"273","author":"Conn","year":"1965","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2019.101365_bib59","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1055\/s-0029-1246189","article-title":"Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn's Registry","volume":"42","author":"Reincke","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.beem.2019.101365_bib60","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2337\/dc07-0031","article-title":"Primary aldosteronism in diabetic subjects with resistant hypertension","volume":"30","author":"Umpierrez","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.beem.2019.101365_bib61","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1479164109350556","article-title":"Type 2 diabetic patients with resistant hypertension should be screened for primary aldosteronism","volume":"7","author":"Mukherjee","year":"2010","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.beem.2019.101365_bib62","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1507\/endocrj.EJ13-0060","article-title":"Prevalence and clinical characteristics of primary aldosteronism in Japanese patients with type 2 diabetes mellitus and hypertension","volume":"60","author":"Murase","year":"2013","journal-title":"Endocr J"},{"key":"10.1016\/j.beem.2019.101365_bib63","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/cen.13370","article-title":"Prevalence of primary aldosteronism among patients with type 2 diabetes","volume":"87","author":"Tancredi","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2019.101365_bib64","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/jamasurg.2015.1683","article-title":"Differences between bilateral adrenal incidentalomas and unilateral lesions","volume":"150","author":"Pasternak","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1016\/j.beem.2019.101365_bib65","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.jacc.2017.02.041","article-title":"The time has come for systematic screening for primary aldosteronism in all hypertensives","volume":"69","author":"Maiolino","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.beem.2019.101365_bib66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mce.2003.10.006","article-title":"Primary aldosteronism--careful investigation is essential and rewarding","volume":"217","author":"Stowasser","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2019.101365_bib67","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1530\/EJE-17-0978","article-title":"Primary aldosteronism: key characteristics at diagnosis: a trend toward milder forms","volume":"178","author":"Heinrich","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2019.101365_bib68","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1530\/EJE-17-0990","article-title":"Management OF endocrine disease: diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited","volume":"179","author":"Williams","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2019.101365_bib69","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11154-011-9163-7","article-title":"Commentary on the Endocrine Society Practice Guidelines: consequences of adjustment of antihypertensive medication in screening of primary aldosteronism","volume":"12","author":"Fischer","year":"2011","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.beem.2019.101365_bib70","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/jch.12523","article-title":"Unadjusted plasma renin activity as a \"first-look\" test to decide upon further investigations for primary aldosteronism","volume":"17","author":"Rye","year":"2015","journal-title":"J\u00a0Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.beem.2019.101365_bib71","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.118.033597","article-title":"Primary aldosteronism","volume":"138","author":"Byrd","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.beem.2019.101365_bib72","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/HJH.0000000000001735","article-title":"Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentration","volume":"36","author":"Baron","year":"2018","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.beem.2019.101365_bib73","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1210\/jc.2018-01041","article-title":"Aldosterone LC-MS\/MS assay-specific threshold values in screening and confirmatory testing for primary aldosteronism","volume":"103","author":"Guo","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101365_bib74","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1507\/endocrj.EJ16-0337","article-title":"Saline infusion test highly associated with the incidence of cardio- and cerebrovascular events in primary aldosteronism","volume":"64","author":"Hayashi","year":"2017","journal-title":"Endocr J"},{"key":"10.1016\/j.beem.2019.101365_bib75","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1210\/jc.2018-01394","article-title":"Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism","volume":"103","author":"Stowasser","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101365_bib76","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2014-1153","article-title":"Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study","volume":"99","author":"Ahmed","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101365_bib77","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41371-018-0094-6","article-title":"Diagnosis of primary aldosteronism in the hypertension specialist centers in Italy: a national survey","volume":"32","author":"Pucci","year":"2018","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.beem.2019.101365_bib78","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1161\/HYPERTENSIONAHA.107.093468","article-title":"Captopril test can give misleading results in patients with suspect primary aldosteronism","volume":"50","author":"Mulatero","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2019.101365_bib79","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/HYPERTENSIONAHA.117.10197","article-title":"Confirmatory tests for the diagnosis of primary aldosteronism: a prospective diagnostic accuracy study","volume":"71","author":"Song","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2019.101365_bib80","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/cen.13943","article-title":"Confirmatory tests for the diagnosis of primary aldosteronism: a systematic review and meta-analysis","volume":"90","author":"Wu","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2019.101365_bib81","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","article-title":"Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism","volume":"151","author":"Kempers","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2019.101365_bib82","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1210\/jc.2013-4146","article-title":"Accuracy of adrenal imaging and adrenal venous sampling in predicting surgical cure of primary aldosteronism","volume":"99","author":"Lim","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101365_bib83","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-8587(16)30100-0","article-title":"Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial","volume":"4","author":"Dekkers","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2019.101365_bib84","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/HYPERTENSIONAHA.118.11382","article-title":"Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism","volume":"72","author":"Williams","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2019.101365_bib85","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/cen.13582","article-title":"Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism","volume":"88","author":"Umakoshi","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2019.101365_bib86","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1210\/jc.2014-2788","article-title":"Outcome of adrenal vein sampling performed during concurrent mineralocorticoid receptor antagonist therapy","volume":"99","author":"Haase","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101365_bib87","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/jc.2018-01299","article-title":"Adrenal vein sampling lateralization despite mineralocorticoid receptor antagonists exposure in primary aldosteronism","volume":"104","author":"Nanba","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101365_bib88","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11906-007-0017-3","article-title":"New concepts in adrenal vein sampling for aldosterone in the diagnosis of primary aldosteronism","volume":"9","author":"Rossi","year":"2007","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.beem.2019.101365_bib89","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2019.101365_bib90","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S2213-8587(14)70069-5","article-title":"Adrenal vein sampling in primary aldosteronism: towards a standardised protocol","volume":"3","author":"Monticone","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2019.101365_bib91","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1055\/a-0662-6081","article-title":"Treatment of unilateral PA by adrenalectomy: potential reasons for incomplete biochemical cure","volume":"127","author":"Yang","year":"2019","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.beem.2019.101365_bib92","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-18-0844","article-title":"Adrenal venous sampling: cosyntropin stimulation or not?","author":"Deinum","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2019.101365_bib93","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/HJH.0000000000001964","article-title":"Impact of adrenocorticotropic hormone stimulation during adrenal venous sampling on outcomes of primary aldosteronism","volume":"37","author":"Takeda","year":"2019","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.beem.2019.101365_bib94","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1148\/radiol.2015142413","article-title":"Adrenal vein sampling in primary aldosteronism: sensitivity and specificity of basal adrenal vein to peripheral vein cortisol and aldosterone ratios to confirm catheterization of the adrenal vein","volume":"277","author":"Mailhot","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.beem.2019.101365_bib95","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/SLA.0b013e3181961d77","article-title":"Rapid cortisol assays improve the success rate of adrenal vein sampling for primary aldosteronism","volume":"249","author":"Auchus","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2019.101365_bib96","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/EJE-11-0287","article-title":"Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates","volume":"165","author":"Betz","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2019.101365_bib97","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1161\/HYPERTENSIONAHA.113.03064","article-title":"Implementation of rapid cortisol during adrenal vein sampling","volume":"63","author":"Hayden","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2019.101365_bib98","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/0004563218760352","article-title":"Improved technical success and radiation safety of adrenal vein sampling using rapid, semi-quantitative point-of-care cortisol measurement","volume":"55","author":"Page","year":"2018","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.beem.2019.101365_bib99","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40292-017-0192-5","article-title":"The intra-procedural cortisol assay during adrenal vein sampling: rationale and design of a randomized study (I-Padua)","volume":"24","author":"Cesari","year":"2017","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.beem.2019.101365_bib100","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1152\/physrev.00026.2015","article-title":"Primary aldosteronism: changing definitions and new concepts of physiology and pathophysiology both inside and outside the kidney","volume":"96","author":"Stowasser","year":"2016","journal-title":"Physiol Rev"},{"key":"10.1016\/j.beem.2019.101365_bib101","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/HYPERTENSIONAHA.113.01601","article-title":"Plasma metanephrine for assessing the selectivity of adrenal venous sampling","volume":"62","author":"Dekkers","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2019.101365_bib102","first-page":"150075","article-title":"Use of plasma metanephrine to aid adrenal venous sampling in combined aldosterone and cortisol over-secretion","volume":"2015","author":"Goupil","year":"2015","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.beem.2019.101365_bib103","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MED.0000000000000148","article-title":"Nuclear imaging in the diagnosis of primary aldosteronism","volume":"22","author":"Powlson","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.beem.2019.101365_bib104","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1210\/jc.2011-1537","article-title":"Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas","volume":"97","author":"Burton","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101365_bib105","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1055\/s-0043-120672","article-title":"The latest developments of functional molecular imaging in the diagnosis of primary aldosteronism","volume":"49","author":"Naruse","year":"2017","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.beem.2019.101365_bib106","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/cen.13942","article-title":"(11) C-Metomidate PET\/CT is a useful adjunct for lateralization of primary aldosteronism in routine clinical practice","volume":"90","author":"O'Shea","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2019.101365_bib107","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","article-title":"Targeting CXCR4 (CXC chemokine receptor type 4) for molecular imaging of aldosterone-producing adenoma","volume":"71","author":"Heinze","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2019.101365_bib108","doi-asserted-by":"crossref","first-page":"E1089","DOI":"10.1210\/jc.2015-2149","article-title":"A\u00a0meta-analysis of somatic KCNJ5 K(+) channel mutations in 1636 patients with an aldosterone-producing adenoma","volume":"100","author":"Lenzini","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101365_bib109","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1172\/JCI91733","article-title":"Macrolides selectively inhibit mutant KCNJ5 potassium channels that cause aldosterone-producing adenoma","volume":"127","author":"Scholl","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.beem.2019.101365_bib110","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/HYPERTENSIONAHA.117.10226","article-title":"Macrolides blunt aldosterone biosynthesis: a proof-of-concept study in KCNJ5 mutated adenoma cells ex\u00a0vivo","volume":"70","author":"Caroccia","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2019.101365_bib111","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/08037051.2018.1436961","article-title":"Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism","volume":"27","author":"Maiolino","year":"2018","journal-title":"Blood Press"},{"key":"10.1016\/j.beem.2019.101365_bib112","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/HYPERTENSIONAHA.114.04453","article-title":"Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism","volume":"65","author":"Satoh","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2019.101365_bib113","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1373\/clinchem.2015.251199","article-title":"Mass spectrometry-based adrenal and peripheral venous steroid profiling for subtyping primary aldosteronism","volume":"62","author":"Eisenhofer","year":"2016","journal-title":"Clin Chem"},{"key":"10.1016\/j.beem.2019.101365_bib114","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jsbmb.2019.01.008","article-title":"Classification of microadenomas in patients with primary aldosteronism by steroid profiling","volume":"189","author":"Yang","year":"2019","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.beem.2019.101365_bib115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/HYPERTENSIONAHA.115.06186","article-title":"Genotype-specific steroid profiles associated with aldosterone-producing adenomas","volume":"67","author":"Williams","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2019.101365_bib116","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism","volume":"62","author":"Rossi","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2019.101365_bib117","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1210\/jc.2018-00617","article-title":"Cortisol excess in patients with primary aldosteronism impacts left ventricular hypertrophy","volume":"103","author":"Adolf","year":"2018","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2019.101365_bib118","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2019.101365_bib119","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","article-title":"Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism","volume":"3","author":"Hundemer","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.beem.2019.101365_bib120","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/HYPERTENSIONAHA.117.10596","article-title":"Adrenalectomy lowers incident atrial fibrillation in primary aldosteronism patients at long term","volume":"71","author":"Rossi","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2019.101365_bib121","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1097\/HJH.0000000000001361","article-title":"Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years","volume":"35","author":"Wu","year":"2017","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.beem.2019.101365_bib122","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","article-title":"Renal outcomes in medically and surgically treated primary aldosteronism","volume":"72","author":"Hundemer","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2019.101365_bib123","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.beem.2019.101365_bib124","article-title":"The primary aldosteronism surgical outcome score for the prediction of clinical outcomes after adrenalectomy for unilateral primary aldosteronism","author":"Burrello","year":"2019","journal-title":"Ann Surg Epub"},{"key":"10.1016\/j.beem.2019.101365_bib125","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1445-5994.1996.tb00600.x","article-title":"Primary hyperaldosteronism: a missed diagnosis in 'essential hypertensives'?","volume":"26","author":"Brown","year":"1996","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.beem.2019.101365_bib126","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.jhh.1001013","article-title":"High prevalence of primary aldosteronism in the Tayside hypertension clinic population","volume":"14","author":"Lim","year":"2000","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.beem.2019.101365_bib127","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0895-7061(02)02969-2","article-title":"High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives","volume":"15","author":"Rossi","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.beem.2019.101365_bib128","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1097\/00004872-200311000-00025","article-title":"High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients","volume":"21","author":"Stowasser","year":"2003","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.beem.2019.101365_bib129","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.jhh.1001554","article-title":"Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the central Europe region","volume":"17","author":"Strauch","year":"2003","journal-title":"J\u00a0Hum Hypertens"},{"key":"10.1016\/j.beem.2019.101365_bib130","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjhyper.2005.01.002","article-title":"Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension","volume":"18","author":"Nishizaka","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.beem.2019.101365_bib131","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study","volume":"371","author":"Douma","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2019.101365_bib132","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1590\/S0066-782X2009000100007","article-title":"Prevalence of primary hyperaldosteronism in a systemic arterial hypertension league","volume":"92","author":"Ribeiro","year":"2009","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.beem.2019.101365_bib133","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1161\/HYPERTENSIONAHA.111.179788","article-title":"Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension","volume":"58","author":"Pedrosa","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.beem.2019.101365_bib134","first-page":"525","article-title":"[Aldosterone\/renin ratio in the diagnosis of primary aldosteronism]","volume":"71","author":"Rios","year":"2011","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.beem.2019.101365_bib135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1472-6823-12-17","article-title":"Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study","volume":"12","author":"Sigurjonsdottir","year":"2012","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.beem.2019.101365_bib136","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/HJH.0b013e328360ddf6","article-title":"Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China","volume":"31","author":"Sang","year":"2013","journal-title":"J\u00a0Hypertens"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X19301162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X19301162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:03:50Z","timestamp":1778616230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X19301162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":136,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1521690X19301162"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2019.101365","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence, diagnosis and outcomes of treatment for primary aldosteronism","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2019.101365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101365"}}